Induction and Maintenance Therapy With Infliximab for Children With Moderate to Severe Ulcerative Colitis

Jeffrey S. Hyams(Connecticut Children's Medical Center), Lakshmi Damaraju(Janssen (Belgium)), Marion Blank(Janssen (Belgium)), Jewel Johanns(Janssen (Belgium)), Cynthia Guzzo(Janssen (Belgium)), Harland S. Winter(Massachusetts General Hospital), Subra Kugathasan(Emory University), Stanley A. Cohen(Troy Gastroenterology), James Markowitz(Cohen Children's Medical Center), Johanna C. Escher(Erasmus MC - Sophia Children’s Hospital), G. Veereman‐Wauters(Queen Fabiola Children's University Hospital), Wallace Crandall(Nationwide Children's Hospital), Robert N. Baldassano(Children's Hospital of Philadelphia), Anne M. Griffiths(Hospital for Sick Children)
Clinical Gastroenterology and Hepatology
December 9, 2011
10.1016/j.cgh.2011.11.026
Cited by 278

Abstract

Related Papers

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
Paul Rutgeerts, William J. Sandborn, Brian G. Feagan et al.|New England Journal of Medicine|2005|3.9k
Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative Colitis
Kenneth W. Schroeder, William J. Tremaine, Duane M. Ilstrup|New England Journal of Medicine|1987|3k
Development, Validation, and Evaluation of a Pediatric Ulcerative Colitis Activity Index: A Prospective Multicenter Study
Dan Turner, Anthony Otley, David R. Mack et al.|Gastroenterology|2007|1.1k
Induction and Maintenance Infliximab Therapy for the Treatment of Moderate-to-Severe Crohn’s Disease in Children
Jeffrey S. Hyams, Wallace Crandall, Subra Kugathasan et al.|Gastroenterology|2006|868
Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine
Ahmed Kandiel, A G Fraser, B I Korelitz et al.|Gut|2005|800